A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry

Gordon, Michael S.; Kinlock, Timothy W.; Schwartz, Robert P.; Fitzgerald, Terrence T.; O’Grady, Kevin E.; Vocci, Frank J.

doi:10.1016/j.drugalcdep.2014.05.011

Cited by 112Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesCriminal Justice and Corrections Analysis

A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry

Open access

Gordon, Michael S., Kinlock, Timothy W., Schwartz, Robert P., Fitzgerald, Terrence T., O’Grady, Kevin E., Vocci, Frank J.·2014·Drug and Alcohol Dependence

DOI 10.1016/j.drugalcdep.2014.05.011PMC PMC4129444

Open this paper in CoChat — free account

Abstract

Background Buprenorphine is a promising treatment for heroin addiction. However, little is known regarding its provision to pre-release prisoners with heroin dependence histories who were not opioid-tolerant, the relative effectiveness of the post-release setting in which it is provided, and gender differences in treatment outcome in this population.Methods This is the first randomized clinical trial of prison-initiated buprenorphine provided to male and female inmates in the US who were previously heroin-dependent prior to incarceration. A total of 211 participants with 3-9 months remaining in prison were randomized to one of four conditions formed by crossing In-Prison Treatment Condition (received buprenorphine vs. counseling only) and Post-release Service Setting (at an opioid treatment center vs. a community health center). Outcome measures were: entered prison treatment; completed prison treatment; and entered community treatment 10 days post-release.Results There was a significant main effect (p=.006) for entering prison treatment favoring the In-Prison buprenorphine Treatment Condition (99.0% vs. 80.4%). Regarding completing prison treatment, the only significant effect was Gender, with women significantly (p<.001) more likely to complete than men (85.7% vs. 52.7%). There was a significant main effect (p=.012) for community treatment entry, favoring the In-Prison buprenorphine Treatment Condition (47.5% vs. 33.7%).Conclusions Buprenorphine appears feasible and acceptable to prisoners who were not opioid-tolerant and can facilitate community treatment entry. However, concerns remain with in-prison treatment termination due to attempted diversion of medication.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.drugalcdep.2014.05.011

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Methadone and buprenorphine maintenance treatments are effective for opioid dependence in prison, jail, and community reentry settings.
“Evidence-based opioid-agonist maintenance therapies for opioid dependence (methadone and buprenorphine) are effective in prison, jail, and community reentry (i.e., parole) settings2–5 but have historically been unavailable or discouraged among criminal justice clients.6–8”
From Extended-release naltrexone to prevent opioid relapse in criminal justice offenders (2016) · cites this paper as [4]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Applied logistic regression
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305 · see citing works
Categorical Data Analysis
Hapeman, D. E., & Agresti, A. (1991) · Technometrics · doi:10.1080/00401706.1991.10484817 · Cited by 9,406 · see citing works
The Fifth Edition of the Addiction Severity Index.
Mclellan, A., Kushner, H., Metzger, D., Peters, R., Smith, I. E., Grissom, G. R., Pettinati, H., & Argeriou, M. (1992) · Journal of Substance Abuse Treatment · doi:10.1016/0740-5472(92)90062-s · Cited by 4,279 · see citing works
A solution to the problem of separation in logistic regression
Heinze, G., & Schemper, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1047 · Cited by 2,711 · see citing works
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654 · see citing works
Substance abuse and dependence in prisoners: a systematic review
Fazel, S., Bains, P., & Doll, H. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01316.x · Cited by 839 · see citing works
Meta‐analysis of drug‐related deaths soon after release from prison
Merrall, E. L. C., Kariminia, A., Binswanger, I. A., HOBBS, M. S. T., Farrell, M., Marsden, J., Hutchinson, S. J., & Bird, S. M. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02990.x · Cited by 689 · see citing works
Categorical Data Analysis.
Lendrem, D. W., & Agresti, A. (1991) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348741 · Cited by 616 · see citing works
Substance Abuse in Women
Greenfield, S. F., Back, S. E., Lawson, K., & Brady, K. T. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.01.004 · Cited by 602 · see citing works
Treating Drug Abuse and Addiction in the Criminal Justice System: Improving Public Health and Safety
Chandler, R. K., Fletcher, B. W., & Volkow, N. D. (2009) · JAMA · doi:10.1001/jama.2008.976 · Cited by 583 · see citing works
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C. L., Kimber, J., Davoli, M., & Breen, R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209 · Cited by 536 · see citing works
Drug Use and Dependence, State and Federal Prisoners, 2004
Mumola, C. J., & Karberg, J. C. (2006) · PsycEXTRA Dataset · doi:10.1037/e560272006-001 · Cited by 481 · see citing works
Drug treatment services for adult offenders: The state of the state
Taxman, F. S., Perdoni, M. L., & Harrison, L. D. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2006.12.019 · Cited by 334 · see citing works
Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors
Binswanger, I. A., Nowels, C., Corsi, K. F., Glanz, J., Long, J., Booth, R. E., & Steiner, J. F. (2012) · Addiction Science & Clinical Practice · doi:10.1186/1940-0640-7-3 · Cited by 329 · see citing works
Collaborative Care of Opioid-Addicted Patients in Primary Care Using Buprenorphine: Five-Year Experience
Alford, D. P., LaBelle, C. T., Kretsch, N., Bergeron, A., Winter, M., Botticelli, M., & Samet, J. H. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.541 · Cited by 267 · see citing works
Four‐year follow‐up of imprisoned male heroin users and methadone treatment: mortality, re‐incarceration and hepatitis C infection
Dolan, K. A., Shearer, J., White, B., Zhou, J., Kaldor, J. M., & WODAK, A. D. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01050.x · Cited by 243 · see citing works
A randomized clinical trial of methadone maintenance for prisoners: Results at 12 months postrelease
Kinlock, T. W., Gordon, M. S., Schwartz, R. P., Fitzgerald, T. T., & O'Grady, K. E. (2009) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2009.03.002 · Cited by 235 · see citing works
Self-citation
Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.006 · Cited by 223 · see citing works
A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post‐release
Gordon, M. S., Kinlock, T. W., Schwartz, R. P., & O’Grady, K. E. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.002238.x · Cited by 176 · see citing works
Self-citation
Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States
Rosenblum, A., Cleland, C. M., Fong, C., Kayman, D. J., Tempalski, B. J., & Parrino, M. W. (2011) · Journal of Environmental and Public Health · doi:10.1155/2011/948789 · Cited by 161 · see citing works
The impact of substitution treatment in prisons—A literature review
Stallwitz, A., & Stöver, H. (2007) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2006.11.015 · Cited by 117 · see citing works
Diversion and abuse of buprenorphine: Findings from national surveys of treatment patients and physicians
Johanson, C., Arfken, C. L., di Menza, S., & Schuster, C. R. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.07.019 · Cited by 114 · see citing works
Risk factors for all-cause, overdose and early deaths after release from prison in Washington state
Binswanger, I. A., Blatchford, P. J., Lindsay, R. G., & Stern, M. F. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.11.029 · Cited by 113 · see citing works
Studying Addicts over Time: Methodology and Preliminary Findings
Nurco, D. N., Bonito, A. J., Lerner, M., & Balter, M. B. (1975) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952997509002733 · Cited by 102 · see citing works
Initiation of buprenorphine during incarceration and retention in treatment upon release
Zaller, N. D., McKenzie, M., Friedmann, P. D., Green, T. C., McGowan, S. K., & Rich, J. D. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.02.005 · Cited by 94 · see citing works
Buprenorphine in the treatment of opioid dependence
Davids, E. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00146-9 · Cited by 91 · see citing works
Drugs, Detention, and Death
Krinsky, C. S., Lathrop, S. L., Brown, P., & Nolte, K. B. (2009) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0b013e3181873784 · Cited by 90 · see citing works
A Long-Term Program of Research on Drug Use and Crime
Nurco, D. N. (1998) · Substance Use & Misuse · doi:10.3109/10826089809059323 · Cited by 89 · see citing works
Diversion of Buprenorphine/Naloxone Coformulated Tablets in a Region with High Prescribing Prevalence
Monte, A. A., Mandell, T. W., Wilford, B. B., Tennyson, J. C., & Boyer, E. W. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903014767 · Cited by 88 · see citing works
Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison
Strang, J., Gossop, M., Heuston, J., Green, J., Whiteley, C., & Maden, A. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01475.x · Cited by 80 · see citing works
Post-marketing Surveillance of Methadone and Buprenorphine in the United States
Dasgupta, N., Bailey, E. J., Cicero, T. J., Inciardi, J. A., Parrino, M. W., Rosenblum, A., & Dart, R. C. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00877.x · Cited by 79 · see citing works
Drug use and opioid substitution treatment for prisoners
Stöver, H., & Michels, I. I. (2010) · Harm Reduction Journal · doi:10.1186/1477-7517-7-17 · Cited by 78 · see citing works
Self-report of Longitudinal Substance Use: A Comparison of the UCLA Natural History Interview and the Addiction Severity Index
Murphy, D., Hser, Y., Huang, D. Y. C., Brecht, M., & Herbeck, D. M. (2010) · Journal of Drug Issues · doi:10.1177/002204261004000210 · Cited by 56 · see citing works
Buprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico
Garcia, C. A., Correa, G. C., Viver, A. D. H., Kinlock, T., Gordon, M., Avila, C. A., Reyes, I., & Schwartz, R. (2007) · Journal of addiction medicine · doi:10.1097/adm.0b013e31814b8880 · Cited by 53 · see citing works
Self-citation
Prediction of the Criminal Activity of Incarcerated Drug-Abusing Offenders
Kinlock, T. W., O’Grady, K. E., & Hanlon, T. E. (2003) · Journal of Drug Issues · doi:10.1177/002204260303300406 · Cited by 49 · see citing works
Self-citation
Buprenorphine-Naloxone Maintenance following Release from Jail
Lee, J. D., Grossman, E., Truncali, A., Rotrosen, J., Rosenblum, A., Magura, S., & Gourevitch, M. N. (2012) · Substance Abuse · doi:10.1080/08897077.2011.620475 · Cited by 47 · see citing works
Drug use and health among prison inmates
Kanato, M. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282fc985c · Cited by 45 · see citing works
Comparison of Buprenorphine Treatment for Opioid Dependence in 3 Settings
Miotto, K. A., Hillhouse, M. P., Donovick, R. A., Cunningham‐Rathner, J., Charuvastra, C., Torrington, M., Esagoff, A. E., & Ling, W. W. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e318233d621 · Cited by 43 · see citing works
Developing and Implementing a New Prison-Based Buprenorphine Treatment Program
Kinlock, T. W., Gordon, M., Schwartz, R. P., & Fitzgerald, T. T. (2010) · Journal of Offender Rehabilitation · doi:10.1080/10509670903534951 · Cited by 34 · see citing works
Self-citation
Prisons and Drugs: A global review of incarceration, drug use and drug services. Report 12
Dolan, K. A., Khoei, E. M., Brentari, C., & Stevens, A. (2007) · Kent Academic Repository (University of Kent) · Cited by 32 · see citing works
[Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis].
Levasseur, L., Marzo, J., Ross, N., & Blatier, C. (2002) · PubMed · Cited by 28 · see citing works
Psychological performance and sedation following injectable opioid administration
Forzisi, L., Mitchell, T. B., Bond, A. J., Lintzeris, N., Spofforth, N., & Strang, J. (2010) · Research Portal (King's College London) · Cited by 16 · see citing works
Opioid substitution treatment in custodial settings
Kastelič, A., Stöver, H., & Pont, J. (2009) · Carl von Ossiezky University of Oldenburg · Cited by 14 · see citing works
Buprenorphine Misuse, Abuse, and Diversion
Stimmel, B. (2007) · Journal of Addictive Diseases · doi:10.1300/j069v26n03_01 · Cited by 13 · see citing works
African American patients seeking treatment in the public sector: Characteristics of buprenorphine vs. methadone patients
Mitchell, S. G., Kelly, S. M., Gryczynski, J., Myers, C. P., Jaffe, J. H., O’Grady, K. E., Olsen, Y. K., & Schwartz, R. P. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.09.009 · Cited by 12 · see citing works
Self-citation
Evaluation of Opioid-Dependent Prisoners in Oral Opioid Maintenance Therapy
Metz, V. E., Matzenauer, C., Kammerer, K., Winklbaur, B., Ebner, N., Radler, D., & Fischer, G. (2010) · Cited by 9 · see citing works

Flagged first, then by citations

Research works printed but not linked: 3

Center for Substance Abuse Treatment (CSAT) 2004 Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction, TIP 40 Substance Abuse and Mental Health Services Administration Rockville, MD 22514846
Inciardi JA 2008 The War on Drugs IV Prentice Hall Upper Saddle River, NJ
Kinlock TW Gordon MS Schwartz RP Ruiz P Strain E 2011 Incarcerated populations Lowinson & Ruiz’s Substance Abuse: A Comprehensive Textbook Lippincott Williams & Wilkins Philadelphia, PA 881 891

Sorted by citations

Mental health of prisoners: prevalence, adverse outcomes, and interventions
Fazel, S., Hayes, A. J., Bartellas, K., Clerici, M., & Trestman, R. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30142-0 · Cited by 992 · see citing works
Opioid use disorder
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639 · see citing works
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence
Santo, T., Clark, B., Hickman, M., Grebely, J., Campbell, G., Sordo, L., Chen, A. B., Tran, L. T., Bharat, C., Padmanathan, P., et al. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2021.0976 · Cited by 614 · see citing works
Prevention and Treatment of Opioid Misuse and Addiction: A Review
Volkow, N. D., Jones, E. B., Einstein, E. B., & Wargo, E. M. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3126 · Cited by 596 · see citing works
Extended-release naltrexone to prevent opioid relapse in criminal justice offenders
Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Boney, T. Y., Hoskinson, R. A., Wilson, D., McDonald, R., Rotrosen, J., Gourevitch, M. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505409 · Cited by 315 · see citing works
Self-citation
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review
Moore, K. E., Roberts, W., Reid, H. H., Smith, K. M. Z., Oberleitner, L., & McKee, S. A. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.12.003 · Cited by 213 · see citing works
A conceptual model for understanding post-release opioid-related overdose risk
Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0145-5 · Cited by 203 · see citing works
Prescription opioid abuse: Problems and responses
Compton, W. M., Boyle, M., & Wargo, E. M. (2015) · Preventive Medicine · doi:10.1016/j.ypmed.2015.04.003 · Cited by 186 · see citing works
Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review
Malta, M., Varatharajan, T., Russell, C., Pang, M., Bonato, S., & Fischer, B. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1003002 · Cited by 171 · see citing works
Underlying Factors in Drug Overdose Deaths
Dowell, D., Noonan, R. K., & Houry, D. (2017) · JAMA · doi:10.1001/jama.2017.15971 · Cited by 156 · see citing works
The relationship between incarceration history and overdose in North America: A scoping review of the evidence
Mital, S., Wolff, J., & Carroll, J. J. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108088 · Cited by 122 · see citing works
Beyond the walls: Risk factors for overdose mortality following release from the Philadelphia Department of Prisons
Pizzicato, L. N., Drake, R., Domer-Shank, R. B., Johnson, C. C., & Viner, K. M. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.034 · Cited by 114 · see citing works
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder
Fox, A. D., Maradiaga, J., Weiss, L., Sanchez, J., Starrels, J. L., & Cunningham, C. O. (2015) · Addiction Science & Clinical Practice · doi:10.1186/s13722-014-0023-0 · Cited by 101 · see citing works
Predictors of early dropout in outpatient buprenorphine/naloxone treatment
Marcovitz, D. E., McHugh, R. K., Volpe, J., Votaw, V. R., & Connery, H. S. (2016) · American Journal on Addictions · doi:10.1111/ajad.12414 · Cited by 86 · see citing works
The impact of the opioid crisis on U.S. state prison systems
Scott, C. K., Dennis, M. L., Grella, C. E., Mischel, A. F., & Carnevale, J. T. (2021) · Health & Justice · doi:10.1186/s40352-021-00143-9 · Cited by 84 · see citing works
Epidemiology of the U.S. opioid crisis: the importance of the vector
Compton, W. M., & Jones, C. M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14209 · Cited by 82 · see citing works
Association between jail‐based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011–17
Lim, S., Cherian, T., Katyal, M., Goldfeld, K. S., McDonald, R. D., Wiewel, E. W., Khan, M. R., Krawczyk, N., Braunstein, S., Murphy, S. M., et al. (2022) · Addiction · doi:10.1111/add.16071 · Cited by 76 · see citing works
Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data
Hartung, D. M., McCracken, C. M., Nguyen, T. D., Kempany, K. G., & Waddell, E. N. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2023.208971 · Cited by 75 · see citing works
Interventions for incarcerated adults with opioid use disorder in the United States: A systematic review with a focus on social determinants of health
Sugarman, O. K., Bachhuber, M. A., Wennerstrom, A., Bruno, T., & Springgate, B. F. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227968 · Cited by 66 · see citing works
A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release
Gordon, M., Kinlock, T. W., Schwartz, R. P., O’Grady, K. E., Fitzgerald, T. T., & Vocci, F. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.037 · Cited by 65 · see citing works
Self-citation
Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions
Schwartz, R. P., Sharma, A., O’Grady, K. E., Kelly, S., Gryczynski, J., & Mitchell, S. G. (2016) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s81602 · Cited by 63 · see citing works
Self-citation
“I Kicked the Hard Way. I Got Incarcerated.” Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments
Maradiaga, J., Nahvi, S., Cunningham, C. O., Sanchez, J., & Fox, A. D. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.11.004 · Cited by 59 · see citing works
In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine
Mazhnaya, A., Bojko, M. J., Marcus, R., Filippovych, S., Islam, Z., Дворяк, С., & Altice, F. L. (2016) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2015.1127327 · Cited by 54 · see citing works
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings
Dunlop, A. J., White, B., Roberts, J., Cretikos, M. A., Attalla, D., Ling, R., Searles, A., Mackson, J. M., Doyle, M., McEntyre, E., et al. (2021) · Addiction · doi:10.1111/add.15627 · Cited by 52 · see citing works
A Phase 4, Pilot, Open-Label Study of VIVITROL® (Extended-Release Naltrexone XR-NTX) for Prisoners
Gordon, M., Kinlock, T. W., Vocci, F. J., Fitzgerald, T. T., Memisoglu, A., & Silverman, B. L. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.07.005 · Cited by 51 · see citing works
Self-citation
Cost‐effectiveness of extended release naltrexone to prevent relapse among criminal justice‐involved individuals with a history of opioid use disorder
Murphy, S. M., Polsky, D. E., Lee, J. D., Friedmann, P. D., Kinlock, T. W., Nunes, E. V., Bonnie, R. J., Gordon, M., Chen, D. T., Boney, T. Y., et al. (2017) · Addiction · doi:10.1111/add.13807 · Cited by 50 · see citing works
Self-citation
Attitudes Toward Addiction, Methadone Treatment, and Recovery Among HIV-Infected Ukrainian Prisoners Who Inject Drugs: Incarceration Effects and Exploration of Mediators
Polonsky, M., Rozanova, J., Azbel, L., Bachireddy, C., Izenberg, J. M., Kiriazova, T. K., Дворяк, С., & Altice, F. L. (2016) · AIDS and Behavior · doi:10.1007/s10461-016-1375-0 · Cited by 48 · see citing works
Medications for opioid use disorder during incarceration and post-release outcomes
Cates, L., & Brown, A. (2023) · Health & Justice · doi:10.1186/s40352-023-00209-w · Cited by 47 · see citing works
Opioid Use Disorder Stigma, Discrimination, and Policy Attitudes in a National Sample of U.S. Young Adults
Adams, Z. W., Taylor, B. G., Flanagan, E. A., Kwon, E., Johnson-Kwochka, A. V., Elkington, K. S., Becan, J. E., & Aalsma, M. C. (2021) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2020.12.142 · Cited by 46 · see citing works
A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia
Larney, S., ZADOR, D. A., Sindicich, N., & Dolan, K. A. (2016) · Drug and Alcohol Review · doi:10.1111/dar.12442 · Cited by 43 · see citing works
Massachusetts Justice Community Opioid Innovation Network (MassJCOIN)
Evans, E., Stopka, T. J., Pivovarova, E., Murphy, S. M., Taxman, F. S., Ferguson, W. J., Bernson, D., Santelices, C., McCollister, K. E., Hoskinson, R. A., et al. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108275 · Cited by 42 · see citing works
Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community
Paola, A. D., Lincoln, T., Skiest, D. J., Desabrais, M., Altice, F. L., & Springer, S. A. (2014) · Contemporary Clinical Trials · doi:10.1016/j.cct.2014.09.002 · Cited by 36 · see citing works
Interventions for drug-using offenders with co-occurring mental health problems
Perry, A., James, M. M., Burns, L., Hewitt, C. E., Glanville, J., Aboaja, A. M., Thakkar, P. B., Kumar, K. M. S., Pearson, C., Wright, K. E., et al. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010901.pub3 · Cited by 34 · see citing works
Extended-release naltrexone for opioid use disorder started during or following incarceration
Lincoln, T., Johnson, B. D., McCarthy, P., & Alexander, E. (2017) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2017.04.002 · Cited by 32 · see citing works
Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: Rationale and design of a randomized controlled effectiveness trial
Lee, J. D., Friedmann, P. D., Boney, T. Y., Hoskinson, R. A., McDonald, R. D., Gordon, M., Fishman, M. J., Chen, D. T., Bonnie, R. J., Kinlock, T. W., et al. (2015) · Contemporary Clinical Trials · doi:10.1016/j.cct.2015.01.005 · Cited by 29 · see citing works
Self-citation
Interventions for female drug-using offenders
Perry, A., Neilson, M., James, M. M., Glanville, J., Woodhouse, R., & Hewitt, C. E. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010910.pub2 · Cited by 30 · see citing works
Evaluating the implementation of a prisoner re-entry initiative for individuals with opioid use and mental health disorders: Application of the consolidated framework for implementation research in a cross-system initiative
Hanna, J. E., Kubiak, S. P., Pasman, E., Gaba, A., Andre, M. A., Smelson, D. A., & Pinals, D. A. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.06.012 · Cited by 28 · see citing works
Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts
Chatterjee, A., Weitz, M., Savinkina, A. A., Macmadu, A., Madushani, R. W. M. A., Potee, R. A., Ryan, D., Murphy, S. M., Walley, A. Y., & Linas, B. P. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.7036 · Cited by 27 · see citing works
Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment
Gordon, M., Vocci, F. J., Fitzgerald, T. T., O’Grady, K. E., & O’Brien, C. P. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.12.015 · Cited by 23 · see citing works
Self-citation
Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island
Peterson, M., Macmadu, A., Truong, A. Q., Rich, J. D., Pognon, K., Lurie, M. N., Clarke, J. G., & Brinkley‐Rubinstein, L. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.08.015 · Cited by 23 · see citing works
Medication-Assisted Treatment in Problem-solving Courts: A National Survey of State and Local Court Coordinators
Faragó, F., Blue, T. R., Smith, L. R., Witte, J. C., Gordon, M., & Taxman, F. S. (2022) · Journal of Drug Issues · doi:10.1177/00220426221109948 · Cited by 22 · see citing works
Self-citation
Buprenorphine Dose Induction in Non-Opioid-Tolerant Pre-release Prisoners
Vocci, F., Schwartz, R., Wilson, M. E., Gordon, M., Kinlock, T., Fitzgerald, T. T., O'Grady, K., & Jaffe, J. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.001 · Cited by 24 · see citing works
Self-citation
Use of non–prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration
Gryczynski, J., Lee, J. D., Dušek, K., McDonald, R. D., Sharma, A., Malone, M., Monico, L. B., Cheng, A., DeVeaugh‐Geiss, A., & Chilcoat, H. D. (2021) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2021.108349 · Cited by 21 · see citing works
Budget impact tool for the incorporation of medications for opioid use disorder into jail/prison facilities
Ryan, D. A., Montoya, I. D., Koutoujian, P. J., Siddiqi, K., Hayes, E., Jeng, P. J., Cadet, T., McCollister, K. E., & Murphy, S. M. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2022.208943 · Cited by 21 · see citing works
Prison Buprenorphine Implementation and Postrelease Opioid Use Disorder Outcomes
Bovell-Ammon, B. J., Yan, S., Dunn, D., Evans, E., Friedmann, P. D., Walley, A. Y., & Larochelle, M. R. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.2732 · Cited by 21 · see citing works
“We'll be able to take care of ourselves” – A qualitative study of client attitudes toward implementing buprenorphine treatment at syringe services programs
Frost, T., Deutsch, S., Brown, S., Lemien, E., Cunningham, C. O., & Fox, A. D. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1901173 · Cited by 21 · see citing works
A meta-analysis on the effects of incarceration-based opioid substitution treatment
Boksán, K., Dechant, M., Weiss, M., Hellwig, A., & Stemmler, M. P. (2022) · Medicine Science and the Law · doi:10.1177/00258024221118971 · Cited by 20 · see citing works
Does incarceration influence patients’ goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail
Vail, W. L., Faro, E. Z., Watnick, D. L., Giftos, J., & Fox, A. D. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108529 · Cited by 20 · see citing works
Opioid-specific medication-assisted therapy and its impact on criminal justice and overdose outcomes
Strange, C. C., Manchak, S. M., Hyatt, J. M., Petrich, D. M., Desai, A., & Haberman, C. P. (2022) · Campbell Systematic Reviews · doi:10.1002/cl2.1215 · Cited by 19 · see citing works
Extended-Release Naltrexone for Alcohol and Opioid Problems in Missouri Parolees and Probationers
Crits-Christoph, P. F., Lundy, C., Stringer, M. G., Gallop, R., & Gastfriend, D. R. (2015) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2015.03.003 · Cited by 19 · see citing works
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model
Ling, R., White, B., Roberts, J., Cretikos, M. A., Howard, M. V. A., Haber, P., Lintzeris, N., Reeves, P., Dunlop, A. J., & Searles, A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-08687-8 · Cited by 18 · see citing works
Evaluation of Treatment and Other Factors That Lead to Drug Court Success, Substance Use Reduction, and Mental Health Symptomatology Reduction Over Time
Baughman, M., Tossone, K., Singer, M. I., & Flannery, D. J. (2018) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x18789832 · Cited by 18 · see citing works
Interventions for female drug-using offenders
Perry, A., James, M. M., Burns, L., Hewitt, C. E., Glanville, J., Aboaja, A. M., Thakkar, P. B., Kumar, K. M. S., Pearson, C., & Wright, K. E. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010910.pub3 · Cited by 18 · see citing works
Medications for Opioid Use Disorder Among Incarcerated Individuals: a Review of the Literature and Focus on Patient Preference
Puglisi, L. B., Bedell, P. S., Steiner, A., & Wang, E. A. (2019) · Current Addiction Reports · doi:10.1007/s40429-019-00283-x · Cited by 17 · see citing works
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials
Murphy, S. M., Jeng, P. J., Poole, S. A., Jalali, A., Vocci, F. J., Gordon, M., WOODY, G. E., & Polsky, D. E. (2020) · Addiction Science & Clinical Practice · doi:10.1186/s13722-020-00188-5 · Cited by 17 · see citing works
Self-citation
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail
Gordon, M., Mitchell, S. G., Blue, T. R., Vocci, F. J., Fishman, M. J., Murphy, S. M., Couvillion, K., Maher, K. M., Ryan, D., Wenzel, K. R., et al. (2020) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2020.108241 · Cited by 16 · see citing works
Self-citation
Medications for Opioid use Disorder in State Prisons: Perspectives of Formerly Incarcerated Persons
Treitler, P. C., Enich, M., Reeves, D., & Crystal, S. (2022) · Substance Abuse · doi:10.1080/08897077.2022.2060448 · Cited by 14 · see citing works
Reimbursing incarcerated individuals for participation in research: A scoping review
Mambro, A., Afshar, A., Leone, F., Dussault, C., Stoove, M. A., Savulescu, J., Rich, J. D., Rowan, D. H., Sheehan, J., & Kronfli, N. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104283 · Cited by 16 · see citing works
Initiating buprenorphine treatment prior to versus after release from prison: Arrest outcomes
Gordon, M., Blue, T. R., Couvillion, K. A., Schwartz, R. P., O’Grady, K. E., Fitzgerald, T. T., & Vocci, F. J. (2018) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2018.04.010 · Cited by 14 · see citing works
Self-citation
Cost and cost-effectiveness of interim methadone treatment and patient navigation initiated in jail
Zarkin, G. A., Orme, S., Dunlap, L. J., Kelly, S. M., Mitchell, S. G., O’Grady, K. E., & Schwartz, R. P. (2020) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2020.108292 · Cited by 13 · see citing works
Self-citation
Interim methadone and patient navigation in jail: Rationale and design of a randomized clinical trial
Schwartz, R. P., Kelly, S. M., Mitchell, S. G., Dunlap, L. J., Zarkin, G. A., Sharma, A., O’Grady, K. E., & Jaffe, J. H. (2016) · Contemporary Clinical Trials · doi:10.1016/j.cct.2016.06.002 · Cited by 13 · see citing works
Self-citation
Recent Incarceration and Buprenorphine Maintenance Treatment Outcomes among Human Immunodeficiency Virus–Positive Patients
Riggins, D. P., Cunningham, C. O., Ning, Y. M., & Fox, A. D. (2016) · Substance Abuse · doi:10.1080/08897077.2016.1220443 · Cited by 13 · see citing works
Routes of non-traditional entry into buprenorphine treatment programs
Champagne‐Langabeer, T., Swank, M. W., & Langabeer, J. R. (2020) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-020-0252-z · Cited by 13 · see citing works
Prisoners as Patients: The Opioid Epidemic, Medication-Assisted Treatment, and the Eighth Amendment
Linden, M., Marullo, S., Bone, C., Barry, D. T., & Bell, K. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518782926 · Cited by 11 · see citing works
Innovations in efforts to expand treatment for opioid use disorder
Sigmon, S. C. (2019) · Preventive Medicine · doi:10.1016/j.ypmed.2019.105818 · Cited by 11 · see citing works
Deaths in Custody and following Release
Fox, A. D., Moore, A., Binswanger, I. A., & Kinner, S. A. (2019) · Journal of Health and Human Services Administration · doi:10.1177/107937391904100403 · Cited by 10 · see citing works
“A lot of moving parts”: Recovery home challenges linking and housing individuals with criminal legal system involvement
Dewey, J. M., Bell, J. S., Konchak, J. N., Hinami, K., & Watson, D. P. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209473 · Cited by 9 · see citing works
Exploring mental health comorbidities and opioid agonist treatment coverage among people in prison: A national cohort study 2010–2019
Bukten, A., Skjærvø, I., & Stavseth, M. R. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110896 · Cited by 9 · see citing works
Frequent Drug Use and Negative Employment Outcomes among the Criminally Active
Bellair, P. E., Vuolo, M., & LaPlant, E. G. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1388260 · Cited by 9 · see citing works
Impact of prerelease methadone on mortality among people with HIV and opioid use disorder after prison release: results from a randomized and participant choice open-label trial in Malaysia
Bazazi, A. R., Culbert, G. J., Wegman, M. P., Heimer, R., Kamarulzaman, A., & Altice, F. L. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07804-6 · Cited by 8 · see citing works
Access to medications for opioid use disorder for formerly incarcerated individuals during community reentry: a mini narrative review
Chladek, J. S., & Chui, M. A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1377193 · Cited by 8 · see citing works
New Challenges and Opportunities for Opioid Agonist Treatment Access and Retention: A Scoping Review
Power, N., Archambault, L., & Perreault, M. (2024) · Journal of Drug Issues · doi:10.1177/00220426241269828 · Cited by 8 · see citing works
A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment
Gordon, M., Vocci, F. J., Taxman, F. S., Fishman, M. J., Sharma, B., Blue, T. R., & O’Grady, K. E. (2019) · Contemporary Clinical Trials · doi:10.1016/j.cct.2019.02.009 · Cited by 8 · see citing works
Self-citation
Drugs and Addiction Science: NIDA Celebrates 50 Years of Research and Looks to the Future
Volkow, N. D. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230880 · Cited by 8 · see citing works
Unmet need for medication for opioid use disorder among persons who inject drugs in 23 U.S. cities
Handanagić, S., Broz, D., Finlayson, T., Kanny, D., & Wejnert, C. (2024) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2024.111251 · Cited by 7 · see citing works
Treating opioid use disorders in the criminal justice system with pharmacotherapy
Schenk, S., Eisenbarth, H., & Dixon, L. (2020) · Forensic Science International Mind and Law · doi:10.1016/j.fsiml.2020.100009 · Cited by 6 · see citing works
Recovery support specialists inside the jail: a program description of treatment engagement for opioid use disorder
Martin, M. P., Phillips, M. A., Saxon, M., Love, K., Cessna, L., Woodard, D. L., Page, M., Curry, K. H., Paone, A., Pennington-Stallcup, B., et al. (2021) · International Journal of Prisoner Health · doi:10.1108/ijph-12-2020-0102 · Cited by 6 · see citing works
Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine
Blue, T. R., Gordon, M., Schwartz, R. P., Couvillion, K. A., Vocci, F. J., Fitzgerald, T. T., & O’Grady, K. E. (2019) · Addiction Science & Clinical Practice · doi:10.1186/s13722-019-0172-2 · Cited by 6 · see citing works
Self-citation
Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study
Savinkina, A. A., Jurecka, C., Gonsalves, G., & Barocas, J. A. (2023) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2023.104175 · Cited by 5 · see citing works
Combatting the Opioid Crisis From Prison: Initiating Opioid Agonist Therapy
McIntyre, J. L. (2018) · Journal of Forensic Nursing · doi:10.1097/jfn.0000000000000221 · Cited by 5 · see citing works
Medications for Opioid Use Disorder Helpful or Placebo? An Evaluation of the Effectiveness of MOUD in Carceral Settings
Palmieri, M., & Clark, V. A. (2024) · American Journal of Criminal Justice · doi:10.1007/s12103-024-09784-6 · Cited by 4 · see citing works
Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation
Regenstreif, L., Sadik, M., Beaulieu, E., Bodkin, C., Kiefer, L., Guenter, D., Lee, P. W. P., & Kouyoumdjian, F. G. (2022) · Health & Justice · doi:10.1186/s40352-022-00174-w · Cited by 4 · see citing works
Women with opioid use disorders in the criminal justice system: A brief report
Ea, E., & Ma, S. (2015) · Cited by 4 · see citing works
Populations at Special Health Risk: Incarcerated
Macmadu, A., Reddy, M., Tomasulo, A., Coyle, A., & Rich, J. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00342-8 · Cited by 4 · see citing works
Moving Beyond the Medication or Psychosocial Treatment Dichotomy to Address the Opioid Epidemic
Stimmel, M. A., Smelson, D. A., & Finlay, A. K. (2022) · Psychiatric Services · doi:10.1176/appi.ps.202100627 · Cited by 3 · see citing works
Kaum Geschlechtsunterschiede bei Opioidkonsumierenden in Haft
Boksán, K., Weiss, M., Geißelsöder, K., Dechant, M., Endres, J., Breuer, M. M., Stemmler, M., & Wodarz, N. (2023) · Forensische Psychiatrie Psychologie Kriminologie · doi:10.1007/s11757-022-00747-3 · Cited by 3 · see citing works
Treatment initiations and opioid overdoses among recently incarcerated people after adoption of the take-home methadone policy
Barsky, B. A., Yan, S., & Rosenthal, M. B. (2025) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2025.112775 · Cited by 2 · see citing works
Barriers and facilitators to community pharmacist-provided injectable naltrexone for formerly incarcerated individuals during community reentry
Chladek, J. S., & Chui, M. A. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100561 · Cited by 2 · see citing works
Psychopharmacology in the Jail Setting
Kushner, D. B., Stossel, L. M., & Khan, M. A. “. (2023) · doi:10.1093/oso/9780197524794.003.0008 · Cited by 1 · see citing works
Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals
Gordon, M., Blue, T. R., Vocci, F. J., Mitchell, S. G., Wenzel, K. R., & Fishman, M. J. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100261 · Cited by 1 · see citing works
Self-citation
Community pharmacist-administered injectable naltrexone for individuals who were formerly incarcerated: a review of Wisconsin legislation and regulations
Chladek, J. S., & Chui, M. A. (2025) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-025-00647-9 · Cited by 1 · see citing works
Therapeutic Communities and the Judicial System in the United States
Tuck, A. N., & Stossel, L. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-26273-0_8 · Cited by 1 · see citing works
Management of buprenorphine/naloxone therapy in substances abuse consumers in prison: efficacy and safety
Nava, F. A. (2018) · AboutOpen · doi:10.19156/abtpn.2018.0034
Medicolegal Considerations in the Management of Opioid Use Disorder With Buprenorphine in the Correctional Setting
Mitchell, M. N. (2021) · Journal of Correctional Health Care · doi:10.1089/jchc.19.06.0054
Overview and Summary: Substance Use Disorders and Related Concerns: Perspectives from Nurses
Fathi, J. T. (2020) · OJIN The Online Journal of Issues in Nursing · doi:10.3912/ojin.vol25no03manos
Développement de méthodes de classification basées sur l'analyse de concepts formels sous la plateforme WEKA.
Khalfi, B., Cherif, R., Meddouri, N., & Maddouri, M. (2010) · EGC eBooks
Determinants of health-related quality of life among individuals with opioid use disorder, recently released from incarceration
Cadet, T., Jalali, A., Jeng, P. J., Poole, S. A., WOODY, G. E., & Murphy, S. M. (2023) · Addiction Science & Clinical Practice · doi:10.1186/s13722-023-00375-0
Medications for Opioid Use Disorder (MOUDs): What Psychology Service Providers Should Know to Improve Correctional Care
Bassett, S. S., & Delaney, D. J. (2023) · Springer eBooks · doi:10.1007/978-3-031-37480-7_11
Drug Court
Gallagher, J. R., & Nordberg, A. (2023) · doi:10.1093/oso/9780197694732.003.0026
Incarceration and Health: An Overview of Conditions and Solutions
Cullins, Z., Behne, M. F., Macmadu, A., Rich, J. D., & Brinkley‐Rubinstein, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00068-5

A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release
Gordon, M., Kinlock, T. W., Schwartz, R. P., O’Grady, K. E., Fitzgerald, T. T., & Vocci, F. J. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.11.037 · Cited by 65 · see citing works
Self-citation
Results of a pilot randomized controlled trial of buprenorphine for opioid dependent women in the criminal justice system
Cropsey, K. L., Lane, P. S., Hale, G. J., Jackson, D. O., Clark, C. B., Ingersoll, K. S., Islam, M. A., & Stitzer, M. L. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.021 · Cited by 45 · see citing works
Buprenorphine-naloxone Treatment for Pre-release Opioid-dependent Inmates in Puerto Rico
Garcia, C. A., Correa, G. C., Viver, A. D. H., Kinlock, T., Gordon, M., Avila, C. A., Reyes, I., & Schwartz, R. (2007) · Journal of addiction medicine · doi:10.1097/adm.0b013e31814b8880 · Cited by 53 · see citing works
Self-citation
Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial
Magura, S., Lee, J. D., Hershberger, J., Joseph, H., Marsch, L., Shropshire, C., & Rosenblum, A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.08.006 · Cited by 223 · see citing works
Initiation of buprenorphine during incarceration and retention in treatment upon release
Zaller, N. D., McKenzie, M., Friedmann, P. D., Green, T. C., McGowan, S. K., & Rich, J. D. (2013) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2013.02.005 · Cited by 94 · see citing works

Authors: Gordon, M. S., Kinlock, T. W., Schwartz, R. P., Fitzgerald, T. T., O’Grady, K. E., & Vocci, F. J.
Affiliations: Stevenson University (US)
Friends Research Institute (US)
University of Maryland, Baltimore (US)
University of Maryland, College Park (US)
Corresponding author: Gordon, Michael S.
ORCID: Gordon, Michael S.
Schwartz, Robert P.
O’Grady, Kevin E.
Vocci, Frank J.
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2014-09
Volume: 142
Pages: 33-40
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/j.drugalcdep.2014.05.011
PMC: PMC4129444
OpenAlex: W1979097541
Cited by: 112
References: 46
Citations by year: 2026: 3 · 2025: 6 · 2024: 12 · 2023: 12 · 2022: 10 · 2021: 12 · 2020: 9 · 2019: 13 · 2018: 8 · 2017: 5 · 2016: 11 · 2015: 9 · 2014: 1
FWCI: 8.59
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Drug Abuse (R01DA021579)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Social Sciences › Sociology and Political Science › Criminal Justice and Corrections Analysis
Keywords: buprenorphine, heroin addiction, opioid use disorder, opioid-tolerant patients, community-based treatment, gender differences, treatment completion, drug diversion
MeSH terms: Adult, Buprenorphine, Combined Modality Therapy, Counseling, Female, Heroin Dependence, Humans, Male, Middle Aged, Narcotics, Prisoners, Prisons, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks